LEUCOMYCIN A4 ACETATE
UNII HWQ710J6ZZ

Substance Identification & Data

This profile provides standardized clinical and technical data for Leucomycin A4 Acetate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) HWQ710J6ZZ.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 22924-73-8 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

HWQ710J6ZZ

CAS Registry Number

22924-73-8

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

LEUCOMYCIN A4 ACETATE

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C45H71NO17

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

HRUCVTBGGOHZOO-FITRZQGRSA-N

Line notation for describing the chemical structure and connectivity of atoms.

PubChem CID

90671885

Unique identification number in the NCBI database of chemical substances.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C\1=C/[C@@H]([C@@H](C[C@@H]([C@@H]([C@H]([C@@H](CC(O[C@H](C)C/C=C1)=O)OC(=O)C)OC)O[C@@]2(O[C@@H]([C@](O[C@H]3C[C@](C)([C@@H](OC(CCC)=O)[C@H](C)O3)O)([H])[C@@H]([C@H]2OC(=O)C)N(C)C)C)[H])CC=O)C)OC(C)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Leucomycin A4 Acetate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Common Names & Synonyms

2',3,9-TRI-O-ACETYL-LM-A5

KITASAMYCIN A4 ACETATE

KITASAMYCIN A5 ACETATE

LEUCOMYCIN A4 ACETATE

LEUCOMYCIN A5 ACETATE

LEUCOMYCIN A5, TRIACETATE (ESTER)

LEUCOMYCIN V, 2(SUP A),3,9-TRIACETATE 4(SUP B)-BUTANOATE

Systematic Nomenclature

(3R,4R,5S,6R,8R,9R,10E,12E,15R)-3,9-DIACETOXY-5-(4-O-BUTANOYL-2,6-DIDEOXY-3-C-METHYL-.ALPHA.-L-RIBO-HEXOPYRANOSYL-(1->4)-2-O-ACETYL-3,6-DIDEOXY-3-DIMETHYLAMINO-.BETA.-D-GLUCOPYRANOSYLOXY)-6-FORMYLMETHYL-4-METHOXY-8-METHYLHEXADECA-10,12-DIEN-15-OLIDE

SYS

(4R,5S,6S,7R,9R,10R,11E,13E,16R)-6-(((2S,3R,4S,5S,6R)-3-ACETOXY-5-(((2S,4R,5S,6S)-5-(BUTYRYLOXY)-4-HYDROXY-4,6-DIMETHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-4-(DIMETHYLAMINO)-6-METHYLTETRAHYDRO-2H-PYRAN-2-YL)OXY)-5-METHOXY-9,16-DIMETHYL-2-OXO-7-(2-OXOETHYL)OXACYCLOHEXADECA-11,13-DIENE-4,10-DIYL DIACETATE

SYS

External Clinical & Regulatory Resources

Previous UNIIHWQ5KFY3MU

Next UNIIHWR3M9EC3V